Skip to content

High voltage long-term pulsed radiofrequency in the treatment of postherpetic neuralgia: a randomized-controlled study

High voltage long-term pulsed radiofrequency in the treatment of postherpetic neuralgia: a randomized-controlled study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056277
Enrollment
Unknown
Registered
2022-02-03
Start date
2022-02-07
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic neuralgia

Interventions

High-Voltage Group:The initial RF voltage is 65V, and then gradually increases to the maximum voltage that the patient can stand(< 100V)
Standard-Voltage Group:The RF voltage is 65V.

Sponsors

Department of pain, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. The subjects volunteered and signed the informed consent of the test; 2. Subjects aged >= 18 years; 3. Patients diagnosed with unilateral thoracic or lumbar postherpetic neuralgia and pain duration = 6 on admission; 6. Patients who have not received pulsed radiofrequency therapy. 7. Patients did not participate in other clinical trials in the past three months.

Exclusion criteria

Exclusion criteria: 1. Patients with allergy to research drugs and contrast agents; 2. Patients with mental disorders and mental disorders who cannot tolerate minimally invasive surgery; 3. Patients with abnormal coagulation function or using anticoagulants; 4. Patients with severe heart, brain, kidney and liver dysfunction; 5. Patients with pacemakers; 6. Infection of puncture site; 7. Pregnant or puerperal patients; 8. Patients who cannot objectively describe symptoms or score with vas; 9. Patients who could not be followed up 3 months after treatment.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;

Secondary

MeasureTime frame
Pain Relief Rate;Quality of life;Quality of sleep;Mental state;drug dose;Patients' satisfaction;Economic indicators;

Countries

China

Contacts

Public ContactLing Ye

West China Hospital, Sichuan University

floria0207@163.com+86 199 3432 0709

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026